Novo Nordisk A/SLong
Correction Over?
Head and Shoulders pattern complete, we are 32% down from all time high.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.
The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.
Not financial advise, do what's best for you.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.
The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.
Not financial advise, do what's best for you.
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.